Enzolytics Inc (ENZC)

[foxi]

All very good questions.

Add the exclusive license agreement for ITV-1 to your list. I assume that would also transfer to SAGA. ENZC couldn't collect royalties or licensing fees because the patents are owned by The Zhabilov Trust.

From what I can see, ENZC would either get $250M cash to fund whatever it could do with RobustoMed, BioClonetics, International Medical Partners Ltd, and to cover its liabilities

Or some amount of equity in SAGA to be able to profit alongside SAGA which someday earns revenue from Biogenysis and Virogentics, assuming the tech is profitable. This second possibility might be better for ENZC shareholders since it could create ongoing value for ENZC.

Keep in mind Gaurav Chandra, Charles Cotropia, Joseph Cotropia, Suraj Saggar, and Kirsten Bischof would all have new roles under SAGA as well, per the recent PR. Will they have any capacity to also continue work for ENZC?

I would think SAGA would want their services full time, and exclusively, to avoid a conflict of interest. What would that mean for ENZC?